- Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status
-
Kaiho Y, Yamashita , Ito A, Kawasaki Y, Izumi H, Kawamorita N, Adachi H, Mitsuzuka , Arai Y
- KMID: 2427015
- Investig Clin Urol.
- 2016 Sep;57(5):357-363.
- doi: 10.4111/icu.2016.57.5.357
PURPOSE: To evaluate the effects of phosphodiesterase type 5 inhibitor (PDE5i) on urinary continence recovery after bilateral nerve-sparing radical prostatectomy (BNSRP). MATERIALS AND METHODS: Between 2002 and 2012, 137 of 154... -
- CITED
-
- Close
- SHARE
-
- Close
